Professor, Internal Medicine, TX AandM Univ Coll of Med

Oncology

Joanne L. Blum, MD is an expert in the field of Oncology. She went to University of Maryland School of Medicine. University of Maryland School of Medicine is ranked 37 in research and 52 in primary care medicine She received 3 awards: "Meaningful Use Stage 1 Certification", "Fellow (FACP)" and "Super Doctor". Dr. Joanne L. Blum is a published doctor and has 26 publications published. The lastest was: 'Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers.'

Publications

---

• Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers.
• Treatment effect of capecitabine and docetaxel or docetaxel alone by oestrogen receptor status in patients with metastatic breast Cancer: Results of an exploratory ana...
• Molecular Profiling of Human Mammary Gland Links Breast Cancer Risk to a p27(+) Cell Population with Progenitor Characteristics.
• Genome and transcriptome sequencing in prospective metastatic triple-negative breast Cancer uncovers therapeutic vulnerabilities.
• Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast Cancer.
• Dose-Adjusting Capecitabine Minimizes Adverse Effects While Maintaining Efficacy: A Retrospective Review of Capecitabine for Metastatic Breast Cancer.
• Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1 Interacting Genes.
• Genetic Variation in IGF2, HTRA1, and MMP3 and Breast Cancer Risk Among BRCA1 and BRCA2 Carriers.
• Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast Cancer previously treated with an anthracycline, a...
• Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with Cancer risk and mortality.
• Phase III multicenter trial of doxorubicin plus cyclophosphamide followed by paclitaxel compared with doxorubicin plus paclitaxel followed by weekly paclitaxel as adju...
• Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast Cancer previously treated with an anthracycline and a taxane.
• Docetaxel With Cyclophosphamide Is Associated With an OVerall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research...
• Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast Cancer.
• The effect of tamoxifen or exemestane on bone mineral density during the first 2 years of adjuvant treatment of postmenopausal women with early breast Cancer.
• Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic Cancer: a multicenter, prospective study.
• Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast Cancer heavily pretreated with taxanes.
• Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.
• Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast Cancer: report of a Tamoxifen Exemestan...
• Phase II trial of capecitabine and weekly paclitaxel in patients with metastatic breast Cancer previously treated with every-3-week taxane therapy.
• Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast Cancer.
• Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast Cancer.
• Capecitabine/Taxane combination therapy: evolving clinical utility in breast Cancer.
• Phase II study of pemetrexed in patients pretreated with an anthracycline, a taxane, and capecitabine for advanced breast Cancer.
• Family environments of women seeking BRCA1/BRCA2 genetic mutation testing: an exploratory analysis.

Schools

---

• University Of Maryland School Of Medicine

• Michael Reese Hospital and Med Center

• University Of Michigan

Procedures Preformed

---

• Thoracentesis

Conditions Treated

---

• Adrenal Gland Cancer
• Anemia
• Antiphospholipid Syndrome (APS)
• Breast Cancer
• View All

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology

Accepted Insurances

---

Awards

---

• Meaningful Use Stage 1 Certification
• Fellow (FACP)
• Super Doctor

Education

---

• University of Michigan Hospitals and Health Centers
• University of Maryland School of Medicine

Hospital

---

• Baylor University Medical Center

Drug Facts

---

NPI NUMBER		1285676411
NPPES Provider LastName		BLUM
NPPES Provider FirstName		JOANNE
NPPES Provider ZIPCode		752462003
NPPES Provider State		TX
Specialty Description		Hematology/Oncology
Total Claim Count		1276.0
Distinct Opioid Count		2.0
Opioid Claim Count		56.0
Percent Opioid Claims		4.39

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1285676411
Last Name Of The Provider	BLUM
First Name Of The Provider	JOANNE
View All

Similar Doctors

---

	Dr. Barry Brooks, MD This Doctor is OpenDoctor Recommended.
	Dr. Joyce A. O'Shaughnessy, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Houston E. Holmes III, MD This Doctor is OpenDoctor Recommended.
	Dr. Barry C. Mirtsching, MD This Doctor is OpenDoctor Recommended.
	Dr. John E. Pippen Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Jaya V. Juturi, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert B. Berryman, MD This Doctor is OpenDoctor Recommended.
	Dr. Nabeel Sarhill, MD This Doctor is OpenDoctor Recommended.
	Dr. Darshan G. Gandhi, MD This Doctor is OpenDoctor Recommended.
	Dr. Micah M. Burch, MD This Doctor is OpenDoctor Recommended.
	Dr. Kevin D. Courtney, MD This Doctor is OpenDoctor Recommended.
	Dr. Craig C. Childs, MD This Doctor is OpenDoctor Recommended.
	Dr. Melvin E. Harris, MD This Doctor is OpenDoctor Recommended.
	Dr. Beth F. Wright, MD This Doctor is OpenDoctor Recommended.
	Dr. Sirisha Karri, MD This Doctor is OpenDoctor Recommended.
	Ashwani K. Agarwal, MB This Doctor is OpenDoctor Recommended.
	Dr. James D. Kim, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog